Clinical Trial: Levocarnitine in Treating Fatigue in Cancer Patients

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Phase III Randomized Placebo-Controlled Trial to Determine Efficacy of Levocarnitine for Fatigue in Patients With Cancer

Brief Summary:

RATIONALE: Levocarnitine may help improve energy levels in cancer patients.

PURPOSE: This randomized phase III trial is studying how well levocarnitine works compared to a placebo in treating fatigue in cancer patients.